In a wide-ranging conversation with Ezekiel Emanuel, the policymaking physician and medical gadfly, we discuss the massive effects of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro. We also talk about the state of cancer care, mysteries in the gut microbiome, flaws in the U.S. healthcare system — and what a second Trump term means for healthcare policy.
SOURCES:
Ezekiel Emanuel, vice provost for Global Initiatives, co-director of the Health Transformation Institute, and professor at the University of Pennsylvania Perelman School of Medicine.
Podden och tillhörande omslagsbild på den här sidan tillhör Freakonomics Radio + Stitcher. Innehållet i podden är skapat av Freakonomics Radio + Stitcher och inte av, eller tillsammans med, Poddtoppen.